BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,585 | +0.7% | 60,613 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $6,542 | -13.8% | 60,613 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $7,588 | -93.6% | 60,913 | -92.2% | 0.00% | -94.7% |
| Q4 2022 | $117,814 | -99.9% | 784,278 | -37.6% | 0.02% | -32.1% |
| Q3 2022 | $169,451,000 | -38.5% | 1,256,309 | -32.0% | 0.03% | -20.0% |
| Q2 2022 | $275,527,000 | +5.8% | 1,847,935 | +21.0% | 0.04% | +34.6% |
| Q1 2022 | $260,415,000 | -34.3% | 1,526,825 | -0.7% | 0.03% | -27.8% |
| Q4 2021 | $396,425,000 | +24.8% | 1,537,723 | +32.1% | 0.04% | +20.0% |
| Q3 2021 | $317,716,000 | -30.1% | 1,163,839 | -42.7% | 0.03% | -28.6% |
| Q2 2021 | $454,624,000 | +100.7% | 2,030,661 | -2.1% | 0.04% | +82.6% |
| Q1 2021 | $226,559,000 | +76.5% | 2,074,906 | +31.8% | 0.02% | +76.9% |
| Q4 2020 | $128,379,000 | +54.8% | 1,574,821 | +31.5% | 0.01% | +30.0% |
| Q3 2020 | $82,913,000 | +318.3% | 1,197,644 | +303.2% | 0.01% | +400.0% |
| Q2 2020 | $19,822,000 | – | 297,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |